INTECH Investment Management’s Kymera Therapeutics KYMR Stock Holding History

INTECH Investment Management’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Sell	12,412 -1,261	-9%	-$108K	0.01%	861
2026 Q1	$1.14M	Sell	13,673 -7,841	-36%	-$621K	0.01%	954
2025 Q4	$1.67M	Buy	21,514 +6,803	+46%	+$459K	0.01%	834
2025 Q3	$833K	Sell	14,711 -8,279	-36%	-$373K	0.01%	1283
2025 Q2	$1M	Sell	22,990 -9,802	-30%	-$338K	0.01%	1191
2025 Q1	$898K	Buy	32,792 +11,020	+51%	+$402K	0.01%	1269
2024 Q4	$876K	Buy	21,772 +8,045	+59%	+$363K	0.01%	1233
2024 Q3	$650K	Buy	+13,727	New	+$606K	0.01%	1077

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

INTECH Investment Management's KYMR Position: Q2 2026 in Review

INTECH Investment Management reduced its Kymera Therapeutics (KYMR) stake by 9.2% in Q2 2026, selling an estimated $108K and leaving 12,412 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #861.

INTECH Investment Management first reported a position in KYMR in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.67M in Q4 2025. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

INTECH Investment Management held 12,412 shares of Kymera Therapeutics worth $1.42M as of Q2 2026.
INTECH Investment Management sold 1,261 Kymera Therapeutics shares in Q2 2026, an estimated $108K.
Kymera Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #861 holding.
INTECH Investment Management first reported a position in Kymera Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Kymera Therapeutics position peaked at $1.67M in Q4 2025.
275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.